GARY A. LYONS - 22 May 2024 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Director
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Issuer symbol
NBIX
Transactions as of
22 May 2024
Net transactions value
$0
Form type
4
Filing time
23 May 2024, 18:17:56 UTC
Previous filing
21 May 2024
Next filing
18 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBIX Restricted Stock Unit Award $0 +1,435 $0.000000 1,435 22 May 2024 Common Stock 1,435 $0.000000 Direct F1, F2
transaction NBIX Non-Qualified Stock Option Award $0 +2,982 $0.000000 2,982 22 May 2024 Common Stock 2,982 $139.43 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
F2 The RSUs will vest in full on May 22, 2025.
F3 Option vests in 12 monthly installments beginning June 22, 2024.